| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.005 |